Organization | 21st Century Oncology

21st Century Oncology Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Fort Myers FL United States

Organization Overview

First Clinical Trial

2008

NCT00777491

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Alternative names

21st Century Oncology - Michigan Institute for Radiation Oncology

Active Ingredients

Drugs in Phase 3 Trials (8)

bicalutamide (casodex) (1 trial)

buserelin (receptal) (1 trial)

flutamide (eulexin) (1 trial)

goserelin (zoladex) (1 trial)

ibritumomab tiuxetan (Zevalin) (1 trial)

leuprolide (lupron) (1 trial)

rituximab (rituxan) (1 trial)

triptorelin (Trelstar) (1 trial)

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Lymphoma (Phase 3)

Lymphoma, Follicular (Phase 3)

Prostatic Neoplasms (Phase 3)

Urinary Bladder Neoplasms (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 11